Palo Alto Investors LP Gilead Sciences, Inc. Transaction History

Palo Alto Investors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $2.46 Million - $3.15 Million	-39,300 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $8.54 Million - $9.43 Million	-136,600 Reduced 77.66%	39,300 $2.49 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $12.7 Million - $15 Million	175,900	175,900 $14.3 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

Stay updated on Palo Alto Investors LP with notifications on news.